BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

詳細情報 詳細情報について

• CRID

  1363107371056467456

• DOI

  10.1038/s41591-020-0880-x

• ISSN

  1546170X

  10788956

• Web Site

  http://www.nature.com/articles/s41591-020-0880-x.pdf

  http://www.nature.com/articles/s41591-020-0880-x

• データソース種別

  • Crossref